Trials / Completed
CompletedNCT02230956
BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of a single intra-articular injection of 2 doses of BOTOX® (onabotulinumtoxinA) compared with placebo as treatment for knee osteoarthritis symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | onabotulinumtoxinA (botulinum toxin Type A) injection into the intra-articular space of the study knee. |
| DRUG | Normal Saline | Normal Saline (placebo) injection into the intra-articular space of the study knee. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2014-09-03
- Last updated
- 2017-05-31
- Results posted
- 2017-04-20
Locations
3 sites across 3 countries: United States, Czechia, Denmark
Source: ClinicalTrials.gov record NCT02230956. Inclusion in this directory is not an endorsement.